The aim of the present work was to prepare acetazolamide (ACZ) loaded nanoparticle -in-microparticle system (NiMS) using ionotropic-gelated chitosan for formulating orally disintegrating tablets (ODTs). The objective behind the study was to investigate the effect of -concentration of drug (X ), concentration of 1 chitosan (X ) and volume of sodium tripolyphosphate (NaTPP) (X ) on the encapsulation efciency of ACZ 2 3 from NiMS using Box-Behnken Design. The freeze dried optimized NiMS were further formulated into ODTs using direct compression method. The delivery of ACZ by oral route can be an effective way for the treatment of paediatric glaucoma. The encapsulation efciency and loading capacity of NiMS-10 was highest at high levels of chitosan concentration and low levels of volume of NaTPP. The encapsulation efciency and loading capacity of NiMS were lowest at mid levels of volume of NaTPP, which shows that, the proper ratio of chitosan: NaTPP should be present in the formulation for cross linking. A drug entrapment efciency of about 98.53 ± 3.36% (w/w), loading capacity of 99.62 ± 5.77% (w/w) and particle size of 593 nm were achieved for the optimized batch of nanoparticles. Analysis of Variance (ANOVA) was applied on the encapsulation efciency of NiMS to study the tting and the signicance of the model. The mathematical model developed in the present study can be further utilized to design NiMS with desired encapsulation efciency. The batch NiMS-10 showed 96.2% drug release after three hours in phosphate buffer (pH 7.4). Infrared analysis of NiMS-10 showed no interaction between drug and polymer during the formulation process. The particles of NiMS-10 were found spherical in shape. The formulated ODTs have a disintegration time of 35 seconds. The hardness, friability and weight variation of ODTs were found to be within pharmacopoeial limits. In vitro release study revealed that the cumulative percent drug release was found to be 97.8 ± 2.27% in 60 min and the release data followed the rst order kinetics. The NiMS approach has been successfully applied for the preparation of ODT of ACZ. The developed ODT can be advantageous for the treatment of glaucoma in paediatric patients.
INTRODUCTION
During the past decade, the FDT (fast dissolving tablet) technology, which makes tablets dissolve or disintegrate in the mouth without additional water intake, has drawn a great deal of attention. The technology is also referred to as fast disintegrating tablet, fast dispersing tablet, mouth dissolving tablet (MDT), rapid melt tablet, quick disintegrating tablet, and orally disintegrating tablet 1, 2 (ODT) . The FDT formulation is dened by the Food and Drug Administration (FDA) as "a solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed 3 upon the tongue" .
Unfortunately, the quicker disintegrating dosage forms usually have an unpleasant taste, local stimulation, and other side effects caused by short, intense exposure to high concentrations of the active agent. Microencapsulation is a new technique that could be used to control the drug release rate, protect it from premature destruction, and avoid the unpleasant taste by Ms140045 entrapping the active drug into a micro carrier . Spherically shaped and surface-distorted microparticles (embedded with the drug) could lessen the unwanted effects of ODTs by controlling the drug release rate. Recently, a novel nanoparticles-in-microparticles system (NiMS) has been developed using a double emulsion technique and evaluated for drug and gene [5] [6] delivery in specic regions of the gastrointestinal tract . The aim of the present study is to prepare nanoparticlein-microparticle system (NiMS) of ACZ using BBD. The objective behind the work was to study the effects of concentration of drug, concentration of chitosan and volume of NaTPP on the encapsulation efciency of ACZ. Further, the optimized NiMS system was formulated into ODTs.
MATERIALS AND METHODS Materials
Chitosan (95% deacetylated) has a molecular weight of 40-80 kDa, and was supplied by Boi Gen Extracts, Bangalore. Sodium tripolyphosphate (NaTPP) and talc were purchased from Central Drug House, New Delhi.
A c e t a z o l a m i d e w a s o b t a i n e d f r o m K a i z e n Pharmaceuticals, Chandigarh. Sodium starch glycolate (Glaxo SmithKline, Gurgaon), microcrystalline cellulose, mannitol (Loba Cheme Pvt Ltd, Mumbai), magnesium stearate (Shah Scientic, Mumbai) and lactose (Sisco Research Laboratories) were also procured. All other chemicals were of reagent grade.
Methods

Preparation of Acetazolamide loaded Chitosan
Nanoparticles-in-Microparticles (NiMS) 12 For the preparation of NiMS, ionic gelation method was used in the present study. In this method, chitosan (0.5 to 1% w/v) was dissolved in 1% v/v glacial acetic acid. The drug (100 to 300 mg) was added to the solution of chitosan. The volume of chitosan solution in each formulation was kept constant (35 ml). The solution of NaTPP (0.5%w/v) was prepared in distilled water. The solution of NaTPP was added into solution of chitosan at 1 drop/sec. with continuous stirring. A suspension of nanoparticles was formed due to ionic interaction between two oppositely charged ions. The suspension was then puried by centrifugation (20000 rpm, 30 min and at 25ºC) (Remi Compufuge, CPR-30, India). The supernatant was analyzed by HPLC for amount of free drug and solid content was freeze dried (-80ºC) (Allied Frost, Macow Engg., India) to obtain a free owing dry powder.
Optimization of NiMS using Box-Behnken Design
Box-Behnken design (BBD) was utilized to study the effects of three factors on the encapsulation efciency of NiMS for ACZ. The three factors were concentration of drug (X ), concentration of chitosan (X ) and volume of 1 2 NaTPP (X ). The three factors at three levels lead to the 3 thirteen formulations as per BBD (NIMS 1-NIMS 13) are shown in Table 1 . 
Formulation of NiMS based Acetazolamide ODTs
The optimized batch of nanoparticles was utilized to produce ODTs. The nanoparticles equivalent to 20 mg of ACZ were blended along with the other excipients (super disintegrates, diluents, sweetener and lubricant) and processed to tabletting (having a diameter of 1.2 cm, concave faced). The formula for ODTs of ACZ is shown in Table 2 . Encapsulation Efciency (%) = X100 Totaldrug-Freedrug Totaldrug
Totaldrug-Freedrug NanoparticlesWeight
Loading Capacity (%) = X100
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Drug release from the NiMS in vitro
The formulation (NiMS) equivalent to 20 mg of drug, was placed in a dialysis membrane 110 (specication: Av. Flat width-32.34 mm, Av. Diameter-21.5 mm, Capacity-3.63 ml/cm), which was tied from both the sides with a thread. This dialysis membrane was then immersed in a beaker containing 900 ml of phosphate buffer (pH 7.4). Aliquots of dissolution uid (10 ml) were withdrawn at specied time intervals and the beaker was fresh buffer was replenished with equal volume of fresh buffer. The sample withdrawn was estimated by HPLC analysis. Similarly, in vitro release studies were also carried out using the 0.1N HCl as medium.
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Transmission electron microscopy (TEM)
The morphology and surface appearance of the prepared NiMS were studied by transmission electron microscopy. An aqueous solution (1 mg/ml) of the lyophilized chitosan nanoparticles was placed on a TEM grid surface with a lter paper (Whatman No.1). One drop of 1% Uranyl acetate was added to the surface of the carbon coated grid. After one min of incubation, excess uid was removed and the grid surface was air dried at room temperature. It was then loaded into the transmission electron microscope attached to a Gatan SC 1000 CCD camera.
Fourier Transform Infrared (FTIR)
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Spectrophotometry
The FTIR spectra were obtained using the potassium bromide disc method for acetazolamide and drug loaded NiMS-12 on FT-IR-Alpha, Bluker, Germany. The -1 samples were scanned at a range of 400-4000 cm . The infrared spectra were acquired to draw information on drug-excipient compatibility.
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Evaluation of ODTs In vitro disintegration time
The disaggregation test for ODTs was performed at 37 ±0.5°C using a disintegration time apparatus (Excel Enterprises, Kolkata) using phosphate buffer as a dispersion medium. The disintegration time is the time required to transform a tablet immersed in water into small fragments with vertical vibrations at a rate of 30 vibrations per minute. The disintegration time of the six formulations was recorded.
In vitro dissolution study
The release rate of ACZ from immediate release tablets was determined using USP dissolution testing apparatus 2 (Paddle method) (Lab India DS 8000, India). The dissolution test was performed using 900 ml of 0.1N HCl at 37±0.5ºC and 100 rpm. Sample (10 ml) withdrawn at various predetermined intervals was replenished with equal amount of fresh medium. The sample was analysed by HPLC. The results are expressed as a percentage of released drugs as a function of time. 
Tablet Friability
Tablet Hardness
Monsanto Hardness Tester was used to determine the crushing strength. Six tablets were randomly selected from formulation and the pressure at which each tablet was crushed was recorded. The determinations were made in triplicate.
Weight Variation Test
Twenty tablets were weighed individually selected at random, were weighed individually and the average weight was calculated.
RESULTS AND DISCUSSION
TPP is a non-toxic and multivalent anion that can form cross linkages with the positively charged amino groups of CS involving ionic interactions. With the drop wise addition of TPP, the nanoencapsulation was processed with the electrostatic attraction. Meanwhile, with the incorporation of ion TPP to CS solution, the opalescence 19 indicated the formation process of nanoparticles . A total of 13 formulations of NiMS were formulated using BBD for optimization of 3 factors-concentration of drug (X ), concentration of chitosan (X ) and volume of 1 2 NaTPP (X ) at three levels. Analysis of particle size, 3 encapsulation efciency and loading capacity was carried out for all the formulations and is shown in Table  1 . The optimized batch (NiMS-10) has the high encapsulation efciency and loading capacity of 98.53% and 99.62%, respectively with an average particle size of 593 nm. The encapsulation efciency and loading capacity of NiMS-10 was high at high levels of chitosan concentration and low levels of volume of NaTPP, which shows that the proper ratio of chitosan: NaTPP should be present in the formulation for cross linking. BBD was used to study the effect of amount of drug, concentration of chitosan and volume of NaTPP (ml) on the encapsulation efciency. The real values of factors were transformed to facilitate orthogonality of results and each calculation. To determine the magnitude of contribution of different factors towards encapsulation efciency multiple linear regression analysis was performed using Design Expect Software version 8.0.1.0. The effect of coefcients on encapsulation efciency is shown in Figure 1 . The 3D surface of and contour plot of encapsulation efciency are shown in Figures 2 and 3 Where, X = Amount of Drug (mg); X = Concentration of 1 2 chitosan (%w/v); X = Volume of NaTPP (ml) ANOVA was applied on the encapsulation efciency to study the tting and signicance of model in Table 3 . Ftest was carried out to compare the regression mean square with residual mean square the ratio F = 13.22 shows regression to be signicant.
The in vitro drug release study using batch NiMS-10 showed that the release was higher after three hours i.e. 96.2% in phosphate buffer (pH 7.4) and 63% in 0.1 N HCl. Therefore, NiMS-10 was further used for the preparation of ODTs.
The infrared spectrum of NiMS-10 ( Figure 4 ) exhibited no signicant difference in the characteristic peaks when compared to the spectrum of pure ACZ, indicating no interaction between the drug and polymer. The results suggested no incompatibility during the encapsulation process. As observed from the transmission electron microscopic analysis (Leo 0430, Leica Cambridge Ltd., and Cambridge, UK) ( Figure 5 ), the ACZ -loaded NiMS was found to be almost spherical in shape.
ODTs of NiMS (batch NIMS-10) were prepared by direct compression method. The tablets were evaluated for weight variation, hardness, drug content, friability, disintegration and in vitro dissolution rate. It was found that all the evaluation tests of tablets were within the specied range as per Indian Pharmacopoeia (2013) . The results are shown in Table 4 .The disintegration time of the drug was found to be 35 ± 2 seconds.
It has been found that drug released was 97.8 ± 2.27% after 60 minutes by in vitro drug release studies. In vitro drug release at different time intervals is shown in Figure  6 . In order to understand the mechanism and kinetics of drug release from ODT, the in vitro release data was tted to various kinetic equations. Higher correlation (0.994) was observed in rst-order, indicating the rst order release of ACZ from ODT.
CONCLUSION
The ACZ loaded NiMS were successfully formulated by applying ionotropic-gelated chitosan and further formulated into ODTs using direct compression technique. The mathematical model developed in the present study can be used to formulate NiMS of ACZ with desired encapsulation efciency. The ODT developed using NiMS disintegrate quickly i.e. within 35 seconds. Therefore, the ODT developed in the present study would be advantageous in case of pediatrics for the treatment of glaucoma. Formulations containing NiMS represent an example of quickly dispersible releasing tablets that are effective alternative to traditional tablets.
